The Primary Clinical Trials Database (https://clinicaltrials.gov) lists one clinical trial examining PPAR-α antagonists in various cancers and 24 clinical trials examining PPAR-γ modulators in cancer treatment, but none have examined PPAR-δ as a prognostic factor. This evidence concerns the gene PPARD and cancer.